Dilemmas in the Use of Active Control Groups in Clinical Research

Institutional Review Boards (IRBs) are commonly called upon to review protocols for comparative Phase III clinical trials. In its review, the IRB must integrate traditional principles of medical ethics with the need for scientifically designed studies that yield sound evidence regarding the efficacy of a new drug. A basic component of the experimental approach is the use of controls, subjects who receive an alternative treatment to which the